Evidence for Use of Cannabinoids to Treat Mental Disorders Lacking
Evidence inadequate for cannabinoid use to relieve depression, anxiety, ADHD, Tourette, PTSD, psychosis
Antidepressant Effect Seen for Anti-Inflammatories in MDD
Review shows reduced depressive symptoms for anti-inflammatory agents compared with placebo in MDD
Facebook Launches Preventive Health Tool
Tool created in partnership with American Cancer Society, American College of Cardiology, AHA, CDC
Psychotherapy for Depression May Be Cost-Effective Over Time
No clear superiority seen on cost basis for second-generation antidepressants versus cognitive therapy
Prevalence of Pain Higher in Children With Autism
Association more pronounced among children with autism plus developmental comorbidities
Outcomes Poor With Medical Care From Fraud, Abuse Perpetrators
Mortality and emergency hospitalization rates higher in Medicare beneficiaries with FAP exposures
One Lot of Generic Form of Xanax Recalled Due to Potential Contaminate
So far, Mylan says it has not received any reports of harm caused by the recalled lot
CDC: Drugs Involved in Overdose Deaths Varied Regionally in 2017
Overdose deaths involving fentanyl or cocaine higher in regions east of Mississippi River
Early-Stage Alzheimer Disease Has Adverse Financial Consequences
Robust evidence shows households are at significant risk for large adverse changes in liquid assets
Family Involvement Cuts Postop Delirium in Older Patients
Patients in elder life program had less decline in physical and cognitive function, shorter length of stay
